Evaluation and Treatment of Patients With Inflammatory Eye Diseases
Choroiditis, Iridocyclitis, Iritis
About this trial
This is an observational trial for Choroiditis focused on measuring Behcet's Disease, Sarcoidosis, Iritis, Choroiditis, Iridocyclitis, Retinal Disease, Cystoid Macular Edema, Uveitis, Intraocular Inflammation, Inflammatory Eye DIsease
Eligibility Criteria
INCLUSION CRITERIA: Patients are initially screened for NEI protocols under the NEI screening protocol or from the closeout of another protocol. Some of these patients will have a uveitic or other intraocular inflammatory condition that NEI staff wishes to follow and treat. Such patients can the be enrolled in this evaluation and treatment protocol. Each study participant must have the ability to understand and sign an informed consent form. EXCLUSION CRITERIA: Patients will be excluded from this study if they are unable or unwilling to give informed consent or the are unwilling to be followed and treated at the NEI clinical center for at least the next 3 years.
Sites / Locations
- National Institutes of Health Clinical Center, 9000 Rockville Pike